February 16th 2022
February 15th 2022
February 15th 2022
Xacduro, A New Weapon in the Fight Against Bacterial Pneumonia: Insights From Clinical Trials and Expert InterviewsMay 26th 2023
The innovative antibiotic Xacduro has received FDA approval for its efficacy against ventilator-associated bacterial pneumonia caused by Acinetobacter baumannii-calcoaceticus. The intravenous therapy combines sulbactam and durlobactamto target multidrug-resistant and carbapenem-resistant strains.
FDA Approves Paxlovid for COVID-19 in Adults, Continues Strategy to Minimize Infection SeverityMay 25th 2023
This is the first oral antiviral to get through the regulatory process and is indicated for the treatment of mild-to-moderate COVID-19 in adults who are at high risk for progression to severe COVID-19, including hospitalization or death.
Evaluating the Benefits and Risks of Fecal Microbiota Transplantation for Recurrent C diffMay 25th 2023
FMT is a promising intervention for immunocompetent patients with recurrent C difficile infection. However, the safety of FMT remains inconclusive due to limited data on serious adverse events and mortality.
FDA Approves Sulbactam-Durlobactam for Bacterial PneumoniaMay 23rd 2023
The antibiotic, marketed as Xacduro, is indicated for hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) caused by susceptible strains of bacteria called Acinetobacter baumannii.
Expanding HCV Care: Effectiveness of Accessible Testing and Treatment for People Who Inject DrugsMay 20th 2023
By implementing rapid point-of-care HCV RNA testing in supervised consumption services, a study achieved high testing acceptance and successful engagement with HCV care among individuals who inject drugs.
AI-Driven Advancements Pave the Way to Test for COVID-19 and Hepatitis at HomeMay 18th 2023
These new tests, conducted in a single tube within minutes, could enable at-home testing for various diseases. By incorporating CRISPR technology, the test achieves high reliability by distinguishing between false and true positives.